Trials / Active Not Recruiting
Active Not RecruitingNCT06289361
Cohort IMEA 070 -Lenacapavir Compassional
Immunovirological Follow-up and Safety of HIV-infected Patients Receiving Lenacapavir Under Compassionate Access in France Between 01/01/2021 and 12/31/2023
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (estimated)
- Sponsor
- Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Immunovirological follow-up and safety of HIV-infected patients receiving lenacapavir under compassionate access in France between 01/01/2021 and 12/31/2023
Detailed description
Retrospective descriptive cohort of patients who received Lenacapavir under compassionate access in France with 50 patients in 25 sites in France
Conditions
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2024-04-15
- Completion
- 2024-11-30
- First posted
- 2024-03-01
- Last updated
- 2024-10-26
Locations
23 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06289361. Inclusion in this directory is not an endorsement.